Anamay Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 25.80%
(FY 2023)
- Profit -60.80%
(FY 2023)
- Ebitda -66.10%
(FY 2023)
- Net Worth 13.64%
(FY 2023)
- Total Assets 303.08%
(FY 2023)
About Anamay Biotech
The Corporate was formerly known as Anamay Biotech (Opc) Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Tripuranenivenkata Chowdary and Jalachari Ella serve as directors at the Company.
- CIN/LLPIN
U73100TG2017PTC117308
- Company No.
117308
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Anamay Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jalachari Ella  | Managing Director | 07-Sep-2021 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tripuranenivenkata Chowdary | Director | 07-Sep-2021 | Current |
Financial Performance of Anamay Biotech.
Anamay Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.8% increase. The company also saw a substantial fall in profitability, with a 60.8% decrease in profit. The company's net worth Soared by an impressive increase of 13.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anamay Biotech?
In 2023, Anamay Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eastman Exports Global Clothing Private LimitedActive 21 years 8 monthsJalachari Ella is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anamay Biotech?
Anamay Biotech has a workforce of 84 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anamay Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anamay Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
